Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | DRD2 | P14416 | 3/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | GOT1 | P17174 | 4/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | HTR6 | P50406 | 3/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7538843 | 0.92 | GAA (0.52) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7534884 | 0.88 | DRD2 (0.47) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7532794 | 0.88 | GAA (0.55) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7532063 | 0.88 | HTR1A (0.48) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7532864 | 0.87 | DRD2 (0.55) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7531514 | 0.83 | GAA (0.58) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7538747 | 0.83 | DRD2 (0.59) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7533281 | 0.83 | DRD2 (0.51) | DRD2DRD4DRD3HTR1AHTR6 | |
| SCHEMBL7538054 | 0.82 | GAA (0.54) | GAAMAPTDRD2DRD4DRD3 | |
| SCHEMBL7538048 | 0.82 | GAA (0.54) | GAAMAPTDRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | H. LUNDBECK A/S (DK) | 2002-09-12 | — | — | US | claimed |
| US-6391882-B1 | PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 2002-05-21 | — | — | US | claimed |
| CN-1336925-A | 4,5,6 and 7-indole and indoline derivatives, their prepn. and use | LUNDBECK & CO AS H (DK) | 2002-02-20 | — | — | CN | claimed |
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | H. LUNDBECK A/S (DK) | 2002-09-12 | — | — | US | disclosed |
| US-6391882-B1 | PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANTS | H. LUNDBECK A/S (DK) | 2002-05-21 | — | — | US | disclosed |
| CN-1336925-A | 4,5,6 and 7-indole and indoline derivatives, their prepn. and use | LUNDBECK & CO AS H (DK) | 2002-02-20 | — | — | CN | disclosed |
| EP-1089997-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H.Lundbeck A/S (DK) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067237-A1 | 4,5,6 AND 7-INDOLE AND INDOLINE DERIVATIVES, THEIR PREPARATION AND USE | H. LUNDBECK A/S (DK) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128272-A1 | 4,5,6, and 7-indole and indoline derivatives, their preparation and use | HTR2C, HTR1A, HTR7 | GAA 4549/4885MAPT 2061/4885DRD2 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.